LDOS Stock Analysis: Leidos Holdings | NYSE

Defense Systems, Cybersecurity, Health IT, Screening Equipment

Total Rating 51

Safety 87

Buy Signal -0.55

Information Technology Services
Industry Rotation: -12.0

Market Cap: 15.5B
Avg Turnover: 163M

Risk 3d forecast

Volatility39.5%

VaR 5^th Pctl5.63%

VaR vs Median-9.51%

Reward TTM

Sharpe Ratio-1.12

Rel. Str. IBD19.4

Rel. Str. Peer Group37.5

Character TTM

Beta0.494

Beta Downside0.523

Hurst Exponent0.526

Drawdowns 3y

Max DD49.47%

CAGR/Max DD0.22

CAGR/Mean DD0.76

EPS (Earnings per Share)

EPS CAGR: 23.47%
EPS Trend: 96.1%

Last SUE: 1.38
Qual. Beats: 2

Revenue

Rev. CAGR: 5.58%
Rev. Trend: 97.4%

Last SUE: 1.20
Qual. Beats: 2

Warnings

Below Avwap Earnings

Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan -0.4% 17

Feb -0.5% 5

Mar +0.7% 5

Apr +1.9% 19

May +0.3% 15

Jun -3.3% 28

Jul +4.0% 31

Aug +4.5% 32

Sep -2.9% 45

Oct +0.5% 5

Nov +0.2% 0

Dec -0.2% 16

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: LDOS Leidos Holdings

Leidos Holdings, Inc. (NYSE: LDOS) is a U.S.-headquartered provider of services and solutions to government and commercial customers, organized into four reporting segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. Founded in 1969, the company is based in Reston, Virginia, and has been publicly traded since 2006.

The National Security & Digital segment delivers defense and intelligence mission support, cyber operations, and digital modernization services leveraging AI/ML. The Health & Civil segment supplies air traffic control systems, managed health services, and life sciences research support. The Commercial & International segment provides power grid engineering and modernization, aviation security screening equipment (people scanners, CT and checked baggage scanners, explosive trace detectors), and integrated airport security management platforms. The Defense Systems segment supplies air and missile defense, maritime, ISR (intelligence, surveillance, reconnaissance), and space-based electro-optic, electronic warfare, and signals intelligence payloads.

Classified within the Industrials sector under Research & Consulting Services, Leidos operates in the federal services and defense contracting industry, where revenue is predominantly generated through long-term, multi-year contracts awarded by U.S. federal agencies via competitive or sole-source procurement processes. This contract-heavy business model typically results in a backlog-weighted revenue profile characteristic of large-scale government integrators.

Headlines to Watch Out For

Defense Systems backlog grows on missile and maritime demand
Federal IT modernization fuels National Security & Digital segment revenue
Labor cost inflation pressures services margins across contracts

Piotroski VR-10 (Strict) 7.0

Net Income: 1.39b TTM > 0 and > 6% of Revenue
FCF/TA: 0.14 > 0.02 and ΔFCF/TA 3.49 > 1.0
NWC/Revenue: 11.49% < 20% (prev 10.75%; Δ 0.74% < -1%)
CFO/TA 0.15 > 3% & CFO 2.30b > Net Income 1.39b
Net Debt (6.38b) to EBITDA (2.32b): 2.74 < 3
Current Ratio: 1.63 > 1.5 & < 3
Outstanding Shares: last quarter (127.0m) vs 12m ago -2.31% < -2%
Gross Margin: 17.42% > 18% (prev 17.56%; Δ -0.14% > 0.5%)
Asset Turnover: 120.9% > 50% (prev 125.9%; Δ -5.00% > 0%)
Interest Coverage Ratio: 9.06 > 6 (EBIT TTM 2.02b / Interest Expense TTM 223.0m)

Altman Z'' 3.41

A: 0.13 (Total Current Assets 5.25b - Total Current Liabilities 3.22b) / Total Assets 15.6b
B: 0.33 (Retained Earnings 5.22b / Total Assets 15.6b)
C: 0.14 (EBIT TTM 2.02b / Avg Total Assets 14.6b)
D: 0.51 (Book Value of Equity 5.28b / Total Liabilities 10.3b)
Altman-Z'' = 3.41 = A

Beneish M -2.97

DSRI: 0.98 (Receivables 2.97b/2.92b, Revenue 17.6b/17.1b)
GMI: 1.01 (GM 17.56% / 17.42%)
AQI: 1.07 (AQ_t 0.58 / AQ_t-1 0.54)
SGI: 1.03 (Revenue 17.6b / 17.1b)
TATA: -0.06 (NI 1.39b - CFO 2.30b) / TA 15.6b)
Beneish M = -2.97 (Cap -4..+1) = A

What is the price of LDOS shares?

As of September 30, 2026, the stock is trading at USD 122.35 with a total of 960,258 shares traded. Over the past week, the price has changed by -4.59%, over one month by -12.73%, over three months by +22.21% and over the past year by -33.32%.

Current recommended Stop Loss: 117.80 (which is 3.7% or 1.2 ATR below the current price).

Is LDOS a buy, sell or hold?

Leidos Holdings has received a consensus analysts rating of 4.06. Therefore, it is recommended to buy LDOS.

StrongBuy: 8
Buy: 2
Hold: 7
Sell: 0
StrongSell: 0

What are the forecasts/targets for the LDOS price?

Analysts Target Price	157.3	28.5%

Leidos Holdings (LDOS) - Fundamental Data Overview as of 28 September 2026

Market Cap USD = 15.5b (15.5b USD * 1.0 USD.USD)
P/E Trailing = 11.5523
P/E Forward = 9.5511
P/S = 0.8817
P/B = 2.9613
P/EG = 2.4573
Revenue TTM = 17.6b USD
EBIT TTM = 2.02b USD
EBITDA TTM = 2.32b USD
Long Term Debt = 6.01b USD (from longTermDebt, last quarter)
Short Term Debt = 22.0m USD (from shortTermDebt, last quarter)
Debt = 7.12b USD (from shortLongTermDebtTotal, last quarter) + Leases 547.0m
Net Debt = 6.38b USD (calculated: Debt 7.12b - CCE 748.0m)
Enterprise Value = 21.9b USD (15.5b + Debt 7.12b - CCE 748.0m)
Interest Coverage Ratio = 9.06 (Ebit TTM 2.02b / Interest Expense TTM 223.0m)
EV/FCF = 10.12x (Enterprise Value 21.9b / FCF TTM 2.16b)
FCF Yield = 9.88% (FCF TTM 2.16b / Enterprise Value 21.9b)
FCF Margin = 12.27% (FCF TTM 2.16b / Revenue TTM 17.6b)
Net Margin = 7.86% (Net Income TTM 1.39b / Revenue TTM 17.6b)
Gross Margin = 17.42% ((Revenue TTM 17.6b - Cost of Revenue TTM 14.6b) / Revenue TTM)
Gross Margin QoQ = 17.92% (prev 17.30%)
Tobins Q-Ratio = 1.40 (Enterprise Value 21.9b / Total Assets 15.6b)
Interest Expense / Debt = 3.13% (Interest Expense 223.0m / Debt 7.12b)
Taxrate = 11.31% (202.2m / 1.79b)
NOPAT = 1.79b (EBIT 2.02b * (1 - 11.31%))
Current Ratio = 1.63 (Total Current Assets 5.25b / Total Current Liabilities 3.22b)
Debt / Equity = 1.35 (Debt 7.12b / totalStockholderEquity, last quarter 5.28b)
Debt / EBITDA = 2.74 (Net Debt 6.38b / EBITDA 2.32b)
Debt / FCF = 2.95 (Net Debt 6.38b / FCF TTM 2.16b)
Total Stockholder Equity = 5.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.50% (Net Income 1.39b / Total Assets 15.6b)
RoE = 27.55% (Net Income TTM 1.39b / Total Stockholder Equity 5.03b)
RoCE = 18.31% (EBIT 2.02b / Capital Employed (Equity 5.03b + L.T.Debt 6.01b))
RoIC = 15.34% (NOPAT 1.79b / Invested Capital 11.7b)
WACC = 6.16% (E(15.5b)/V(22.6b) * Re(7.72%) + D(7.12b)/V(22.6b) * Rd(3.13%) * (1-Tc(0.11)))
Discount Rate = 7.72% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.31 | Cagr: -3.31%
[DCF] Terminal Value 77.97% ; FCFF base≈1.86b ; Y1≈2.13b ; Y5≈3.14b
[DCF] Fair Price = 325.2 (EV 47.2b - Net Debt 6.38b = Equity 40.8b / Shares 125.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.06 | EPS CAGR: 23.47% | SUE: 1.38 | # QB: 2
Revenue Correlation: 97.40 | Revenue CAGR: 5.58% | SUE: 1.20 | # QB: 2
EPS current Quarter (2026-09-30): EPS=3.05 | Chg30d=+0.00% | Revisions=-64% | Analysts=14
EPS current Year (2026-12-31): EPS=12.40 | Chg30d=+0.00% | Revisions=+27% | GrowthEPS=+3.4% | GrowthRev=+6.7%
EPS next Year (2027-12-31): EPS=12.75 | Chg30d=-0.25% | Revisions=-53% | GrowthEPS=+2.8% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: -34% (up=11, down=24)